Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Vera Damyanova"'
Autor:
Dragomira Nikolova, Aleksandar Yordanov, Aleksandra Maslarova, Radka Hristoskova, Vera Damyanova, Savina Hadjidekova, Atanas Radinov
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 38, Iss 1 (2024)
Rosai-Dorfman (RDD) is a rare histiocytic syndrome with variable clinical characteristics and extranodal involvement in more than 43% of the patients. This mini-review presents an overview of the literature on Rosai-Dorfman disease. The histological
Externí odkaz:
https://doaj.org/article/7d9b90f254ee4b63827cbb930c54701e
Autor:
Sena Karachanak-Yankova, Dimitar Serbezov, Marta Mihaylova, Dragomira Nikolova, Lubomir Balabanski, Vera Damyanova, Olga Antonova, Rada Staneva, Mihail Ganev, Victoria Spasova, Blaga Rukova, Desislava Nesheva, Slavica Josifovska, Mikaela Stancheva, Diana Belejanska, Mariya Petrova, Shima Mehrabian, Latchezar Traykov, Savina Hadjidekova, Draga Toncheva
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 37, Iss 1, Pp 74-78 (2023)
AbstractIn an effort to better understand the complex genetic background of Alzheimer’s disease (AD) we performed high-coverage whole-exome sequencing of a DNA pool assembled of 66 Bulgarian AD patients. We focused our analysis on genes demonstrate
Externí odkaz:
https://doaj.org/article/9f16b95efe9046c1b5858050d17509bf
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 35, Iss 1, Pp 650-656 (2021)
Targeted therapy with tyrosine kinase inhibitors (TKIs) was introduced for the suppression of BCR-ABL fusion protein in chronic myelogenic leukemia (CML) more than 50 years ago. The introduction of TKI was an elegant way to gain control over the dise
Externí odkaz:
https://doaj.org/article/316180cc964f40958544dea1cc5294c8
Autor:
Lubomir Balabanski, Dimitar Serbezov, Maya Atanasoska, Sena Karachanak-Yankova, Savina Hadjidekova, Dragomira Nikolova, Olga Boyanova, Rada Staneva, Radoslava Vazharova, Marta Mihailova, Vera Damyanova, Desislava Nesheva, Diana Belejanska, Shima Mehrabian, Lachezar Traykov, Draga Toncheva
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 35, Iss 1, Pp 1256-1262 (2021)
Contemporary genetic methods have not yet solved the ‘missing heritability’ problem of complex diseases such as Alzheimer’s disease (AD). The impact of rare or less common variation on human complex diseases and traits remains to date barely in
Externí odkaz:
https://doaj.org/article/69eab2e91aa343ae9dd277605a11f652
Autor:
Marta Mihaylova, Dimitar Serbezov, Lubomir Balabanski, Sena Karachanak-Yankova, Dragomira Nikolova, Vera Damyanova, Savina Hadzhidekova, Draga Toncheva
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 34, Iss 1, Pp 690-697 (2020)
Overweight and obesity are serious and an ever-growing problem in modern society. It is a major risk factors for a number of chronic diseases, including type 2 diabetes, cardiovascular diseases and cancer. Obesity is a complex condition resulting fro
Externí odkaz:
https://doaj.org/article/77ee2932d79048f2ae77b1960d7d49c1
Autor:
Mihail Ganev, Lubomir Balabanski, Dimitar Serbezov, Sena Karachanak-Yankova, Radoslava Vazharova, Desislava Nesheva, Zora Hammoudeh, Dragomira Nikolova, Olga Antonova, Rada Staneva, Marta Mihaylova, Vera Damyanova, Savina Hadjidekova, Draga Toncheva
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 33, Iss 1, Pp 1757-1765 (2019)
Coronary heart disease (CHD) is a major cause of mortality and morbidity in Europe. CHD is usually caused by atherosclerosis. Despite extensive studies that have identified a large number of genetic variants, strong evidence of association with CHD a
Externí odkaz:
https://doaj.org/article/bb04476f30124e098a0c0d56ae2bf45c
Autor:
Lubomir Balabanski MSc, Dimitar Serbezov PhD, Dragomira Nikolova PhD, Olga Antonova PhD, Desislava Nesheva PhD, Zora Hammoudeh PhD, Radoslava Vazharova PhD, Sena Karachanak-Yankova PhD, Rada Staneva PhD, Marta Mihaylova PhD, Vera Damyanova PhD, Savina Hadjidekova PhD, Draga Toncheva PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Objectives: The aim of the present study was to evaluate the clinical relevance of mutations in tumor suppressor genes using whole-exome sequencing data from centenarians and young healthy individuals. Methods: Two pools, one of centenarians and one
Externí odkaz:
https://doaj.org/article/0fe8fad5d789431cae223b2e68b77e63
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 35, Iss 1, Pp 650-656 (2021)
Targeted therapy with tyrosine kinase inhibitors (TKIs) was introduced for the suppression of BCR-ABL fusion protein in chronic myelogenic leukemia (CML) more than 50 years ago. The introduction of TKI was an elegant way to gain control over the dise
Autor:
Sena Karachanak-Yankova, Draga Toncheva, Marta Mihailova, Olga Boyanova, Dimitar Serbezov, Diana Belejanska, Lubomir Balabanski, Desislava Nesheva, Shima Mehrabian, Rada Staneva, Maya Atanasoska, Dragomira Nikolova, Vera Damyanova, Lachezar Traykov, Radoslava Vazharova, Savina Hadjidekova
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 35, Iss 1, Pp 1256-1262 (2021)
Contemporary genetic methods have not yet solved the ‘missing heritability’ problem of complex diseases such as Alzheimer’s disease (AD). The impact of rare or less common variation on human complex diseases and traits remains to date barely in
Publikováno v:
Acta Medica Bulgarica, Vol 47, Iss 3, Pp 22-25 (2020)
Gaucher disease (GD) is a multi-systemic disease with a low population frequency. It is a lysosomal storage disorder (LSD) that causes accumulation of glucocerebroside in the so called Gaucher cells predominantly in areas like the spleen, liver and b